Label: GLYTONE ACNE CLEARING TONER- salicylic acid liquid

  • NDC Code(s): 64760-733-01, 64760-733-02
  • Packager: Pierre Fabre USA Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated April 29, 2024

If you are a consumer or patient please visit this version.

  • Drug Facts

  • Purpose

    Acne Treatment

  • Active Ingredient

    Salicylic Acid 2%

  • Use

    For the treatment of acne.

    Dries and clears acne blemishes and allows skin to heal.

    Penetrates pores to eliminate most acne blemishes, black-heads and whiteheads.

    Helps prevent the development of new acne blemishes, blackheads and whiteheads.

  • Warnings

    For external use only.

    Flammable: Keep away from fire or flame

    When using this product

    Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

    Avoid contact with eyes. If eye contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if rash occurs.

    Keep out of reach of children.

    If swallowed get medical help or contact a Poison Control Center right away.

  • Directions

    After cleansing, apply toner to a cotton pad and gently apply over affected area one to three times daily.

    Do not rinse.

    Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.

    If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

  • Inactive ingredients

    WATER (AQUA), DEXTRIN, POLYDEXTROSE, 1,2-HEXANEDIOL, CAPRYLYL GLYCOL, POLYSORBATE 20, PROPANEDIOL, AMYLOPECTIN, NIACINAMIDE, GLYCERIN, EPILOBIUM FLEISCHERI EXTRACT, CITRIC ACID, POTASSIUM SORBATE, ALLANTOIN, MANDELIC ACID, SALIX ALBA (WILLOW) BARK EXTRACT, SERENOA SERRULATA FRUIT EXTRACT, ALOE BARBADENSIS LEAF JUICE, PYRUS MALUS (APPLE) FRUIT EXTRACT, CALENDULA OFFICINALIS FLOWER EXTRACT, GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT, HAMAMELIS VIRGINIANA (WITCH HAZEL) BARK/LEAF/TWIG EXTRACT, LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE, SODIUM BENZOATE, SODIUM HYDROXIDE

  • Principal Display Panel - 200 mL

    GLYTONE

    Acne Clearing Toner

    Acne Therapy

    2% Salicylic Acid Acne Medication Niacinamide

    200 mL / 6.76 FL. OZ.

    acne clearing toner

  • INGREDIENTS AND APPEARANCE
    GLYTONE ACNE CLEARING TONER 
    salicylic acid liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:64760-733
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg
    Inactive Ingredients
    Ingredient NameStrength
    POLYDEXTROSE (UNII: VH2XOU12IE)  
    WHEY PROTEIN HYDROLYSATE (UNII: 237DZG2JLA)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    EPILOBIUM FLEISCHERI WHOLE (UNII: 8E2KLS8J8K)  
    ALLANTOIN (UNII: 344S277G0Z)  
    MANDELIC ACID (UNII: NH496X0UJX)  
    SAW PALMETTO (UNII: J7WWH9M8QS)  
    SALIX ALBA BARK (UNII: 205MXS71H7)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)  
    APPLE (UNII: B423VGH5S9)  
    GLYCYRRHIZA GLABRA (UNII: 2788Z9758H)  
    AMYLOPECTIN, UNSPECIFIED SOURCE (UNII: 4XO4QFV777)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    HAMAMELIS VIRGINIANA LEAF (UNII: T07U1161SV)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    WATER (UNII: 059QF0KO0R)  
    ICODEXTRIN (UNII: 2NX48Z0A9G)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:64760-733-01200 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2021
    2NDC:64760-733-0230 in 1 BOTTLE; Type 0: Not a Combination Product10/01/202101/08/2026
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00610/01/202101/08/2026
    Labeler - Pierre Fabre USA Inc. (117196928)
    Registrant - Pierre Fabre USA Inc. (117196928)